ClinicalTrials.govpublic full text
Efficacy of Individualized Rituximab in Maintaining Remission of Moderate and Severe Systemic Lupus Erythematosus
autoimmune diseases, systemic lupus erythematosus, rituximab, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 969669
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.